本页面由Tiger Trade Technology Pte. Ltd.提供服务

Trevi Therapeutics Inc.

12.93
-0.2600-1.97%
盘后:12.930.00000.00%19:30 EDT
成交量:477.08万
成交额:6,185.48万
市值:18.36亿
市盈率:-36.75
高:13.46
开:13.14
低:12.81
收:13.19
52周最高:20.22
52周最低:9.28
股本:1.42亿
流通股本:1.18亿
量比:1.02
换手率:4.04%
股息:- -
股息率:- -
每股收益(TTM):-0.3518
每股收益(LYR):-0.3173
净资产收益率:-19.66%
总资产收益率:-13.82%
市净率:5.71
市盈率(LYR):-40.75

数据加载中...

2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/23

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/21

重要事件披露

Form 8-K - Current report
2024/10/04

重要事件披露

Form 8-K - Current report
2024/10/01

重要事件披露

Form 8-K - Current report
2024/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/11

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report